Pregled bibliografske jedinice broj: 1067656
Effect of vortioxetine vs. escitalopram on plasma BDNF and platelet serotonin in depressed patients
Effect of vortioxetine vs. escitalopram on plasma BDNF and platelet serotonin in depressed patients // Progress in neuro-psychopharmacology & biological psychiatry, 105 (2021), 110016, 30 doi:10.1016/j.pnpbp.2020.110016 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1067656 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Effect of vortioxetine vs. escitalopram on plasma
BDNF and platelet serotonin in depressed patients
Autori
Dvojković, Anja ; Nikolac Perković, Matea ; Šagud, Marina ; Nedić Erjavec, Gordana ; Mihaljević Peleš, Alma ; Švob Štrac, Dubravka ; Vuksan Ćusa, Bjanka ; Tudor, Lucija ; Kušević, Zorana ; Konjevod, Marcela ; Živković, Maja ; Jevtović, Saša ; Pivac, Nela
Izvornik
Progress in neuro-psychopharmacology & biological psychiatry (0278-5846) 105
(2021);
110016, 30
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
depression ; escitalopram ; plasma BDNF ; platelet serotonin ; patients ; vortioxetine
Sažetak
Escitalopram and vortioxetine are efficacious antidepressants. They directly target serotonin (5-HT) system, but vortioxetine mechanism of action is distinct from the one of selective serotonin reuptake inhibitors (SSRIs). Treatment with SSRIs decrease platelet 5-HT concentration and increase peripheral brain- derived neurotrophic factor (BDNF) levels. Since vortioxetine has a multimodal mechanism of action, it is expected to have a greater effect on circulatory BDNF concentration, compared to conventional antidepressants. This longitudinal study aimed to explore and compare the effects of 4-weeks of treatment with vortioxetine and escitalopram on plasma BDNF and platelet 5-HT concentration in patients with major depressive disorder (MDD). The results revealed that vortioxetine significantly increased plasma BDNF concentration (p=0.018) and significantly decreased platelet 5-HT concentration (p<0.001). Treatment with escitalopram significantly decreased platelet 5-HT concentration (p <0.001), but it did not affect plasma BDNF concentration (p=0.379). Response to vortioxetine was not predicted by baseline plasma BDNF or platelet 5-HT concentration, but response to escitalopram was predicted by baseline platelet 5-HT concentration. These effects might be due to vortioxetine unique mechanism of action, but the clinical implications are unclear. It remains to be determined whether this finding extends during long-term vortioxetine treatment, and which, if any, clinical effects emerge from BDNF increase.
Izvorni jezik
Engleski
Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)
POVEZANOST RADA
Ustanove:
Institut "Ruđer Bošković", Zagreb,
Medicinski fakultet, Zagreb,
Klinika za psihijatriju Vrapče,
Klinički bolnički centar Zagreb
Profili:
Anja Dvojković
(autor)
Gordana Nedić Erjavec
(autor)
Marina Šagud
(autor)
Nela Pivac
(autor)
Saša Jevtović
(autor)
Maja Živković
(autor)
Marcela Konjevod
(autor)
Zorana Kušević
(autor)
Alma Mihaljević-Peleš
(autor)
Dubravka Švob Štrac
(autor)
Lucija Tudor
(autor)
Matea Nikolac Perković
(autor)
Bjanka Vuksan-Ćusa
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE